Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic
stenosis, with the number of procedures and sites offering the procedure steadily rising over …

Medical innovations and novel technologies stand to improve the return on high levels of
health spending in developed countries, particularly in cardiovascular care. However …

Background Inequitable access to high‐technology therapeutics may perpetuate inequities
in care. We examined the characteristics of US hospitals that did and did not establish left …

Background Wide geographic variation in access to transcatheter (TAVR) and surgical
(SAVR) aortic valve replacement exists, but the impact of socioethnic factors on the …

Importance Racial and ethnic minority and socioeconomically disadvantaged patients have
been underrepresented in randomized clinical trials. Efforts have focused on enhancing …

Background Socioeconomic status has increasingly recognized influence on outcomes after
cardiac surgery. However, singular metrics fail to fully capture the socioeconomic context …

Background Rural patients face known healthcare disparities and worse cardiovascular
outcomes compared to urban residents due to inequitable access and delayed care. Few …

Background Disparities in access to care cause negative health consequences for
underserved populations. Economic disparities in structural heart disease (SHD) …

Background Transcatheter aortic valve replacement (TAVR) has changed the landscape of
aortic stenosis (AS) management. Aim To describe and evaluate geographic variation in AS …

The use of transcatheter aortic valve replacement (TAVR) in the United States has been
increasing but with variability. We used a 100% sample of Medicare beneficiaries (MBs) …